Ixcela, Inc.
Proprietary gut microbiome testing platform with personalized nutrition counseling by registered dietitians
- Sector
- Digital health
- Headquarters
- Beverly, MA
- Founded
- 2012
- Latest Form D
- $130K, Mar 2026
- Total capital
- $6.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $6.5M
- 4 Form D · last Mar 2026
- 7 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 9
- 7 pending · first 2018
- Rank in peer group#6 of 312
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$130K
- Private capital raisedForm D · SEC · 3rd filing$3.8M
- Private capital raisedForm D · SEC · 2nd filing$1.8M
- Private capital raisedForm D · SEC · 1st filing$700K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 312 peers
Line = medianDigital health · Platform
- Granted patents#6 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Wayne Ebbel MatsonResearcherDirectorLinked by 6 patents
- Erika Ebbel AngleResearcherExecutive Officer, DirectorLinked by 2 patents
- Colin Ebbel AngleExecutive Officer, DirectorNamed in SEC Form D filings
- Heiner Ebbel DreismannDirectorNamed in SEC Form D filings
- Nick Ebbel SolowayDirectorNamed in SEC Form D filings
- Ronald Ebbel ChwangDirectorNamed in SEC Form D filings
What it has protected
USPTO · 9 granted of 16- GrantedDetection And Modification Of Gut Microbial PopulationUSPTOUS 11,287,420
- GrantedDetection And Modification Of Gut Microbial PopulationUSPTOUS 11,287,419
- GrantedDetection And Modification Of Gut Microbial PopulationUSPTOUS 11,287,418
Show all 16 patent records
- Detection And Modification Of Gut Microbial PopulationMar 29, 2022 · US 11,287,420Granted
- Detection And Modification Of Gut Microbial PopulationMar 29, 2022 · US 11,287,419Granted
- Detection And Modification Of Gut Microbial PopulationMar 29, 2022 · US 11,287,418Granted
- Detection And Modification Of Gut Microbial PopulationMar 29, 2022 · US 11,287,417Granted
- Detection And Modification Of Gut Microbial PopulationJun 22, 2021 · US 11,041,847Granted
- Ipa As A Protective AgentMay 7, 2019 · US 10,278,958Granted
- Treatment Of Virus-based Diseases Of The SkinMar 5, 2019 · US 10,220,066Granted
- Treatment of Virus-Based Diseases of the SkinFeb 26, 2019 · US 10,213,468Granted
- Methods And Devices For Quantitating Blood SamplesJul 17, 2018 · US 10,024,842Granted
- Covalently Bound Metabolites As BiomarkersMar 23, 2017 · Application 15277861Pending
- Detection And Modification Of Gut Microbial PopulationApplication 16258199Pending
- Detection And Modification Of Gut Microbial PopulationApplication PCTUS2021029475Pending
- Treatment Of Virus-based Diseases Of The SkinApplication PCTUS2015035384Pending
- Covalently Bound Metabolites As BiomarkersApplication PCTUS2015013888Pending
- Systems Biology Approach To TherapyApplication PCTUS2014045139Pending
- Modulating The Aryl Hydrocarbon Receptor System To Treat Major Depressive DisorderApplication PCTUS2016027879Pending
Related companies, and why
- HumanAPI Inc.Similar federal contract value in Digital health · null in contracts
- Milkify, Inc.Similar federal contract value in Digital health · null in contracts
- uMETHOD Health, Inc.Similar federal contract value in Digital health · null in contracts
- WiserCare, Inc.Similar federal contract value in Digital health · null in contracts
- Arterys IncSimilar federal contract value in Digital health · null in contracts
- CLEARVOICE, INC.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .